New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages. A key driver of that burden is recognition—or ...

Abbott (NYSE: ABT), the global healthcare leader, announced new data revealing diabetic ketoacidosis (DKA) remains an important, yet often undetected health concern for people living with both Type 1 ...

Please provide your email address to receive an email when new articles are posted on . From 2010 to 2020, cases of diabetic ketoacidosis at delivery rose with a mean annual percentage change of 10.8% ...

Abbott Laboratories (NYSE:ABT) is one of the best healthcare stocks to buy with highest upside potential. Abbott Laboratories ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The incidence of severe diabetic ketoacidosis among ...

Many children who develop type 1 diabetes, the inability to produce insulin and process blood sugar, do not know they have the condition until symptoms arise. These symptoms are often driven by a ...

Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

The study covered in this summary was published in Preprints with The Lancet and has not yet been peer reviewed. Across sites in the UK and Ireland, there was an increase in new-onset pediatric ...

Readmission isn't uncommon for patients with type 1 diabetes, according to a new study. In a review of over 90,000 hospitalizations involving an episode of diabetic ketoacidosis (DKA), about 20.2% of ...

The coronavirus disease (COVID-19) may cause severe disease in high-risk people, including the elderly, people with underlying health conditions such as heart disease and diabetes, and those with ...